Abengoa S.A. Ads (ABGB) 1.02 $ABGB Will 2016 Be Cloudy

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abengoa S.A. Ads (ABGB) 1.02 $ABGB

Will 2016 Be Cloudy for These 2 Solar Companies?
Motley Fool Staff - Motley Fool - Fri Apr 22, 11:05AM CDT
SunEdison and Abengoa , two big players in the solar industry, are both nearing bankruptcy. As established as solar has become as a viable source of energy, the sector still looks far from stable from an investor's standpoint.  In this segment...
TSLA: 216.78 (+0.84), SCTY: 23.80 (-0.74), SUNE: 0.34 (unch), ABGB: 1.02 (-0.36)

Why Shares of Abengoa SA Plunged 56% in November
Travis Hoium, The Motley Fool - Motley Fool - Sat Dec 05, 6:03AM CST
What: Shares of energy developer Abengoa SA   dropped a whopping 56% in the month of November and show no signs of recovering anytime soon. So what: Abengoa has been struggling with operations for a while, but thought it had a lifeline from...
ABY: 20.32 (+0.96), ABGB: 1.02 (-0.36)

Why HP, Abengoa, and Petroleo Brasileiro Slumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Wed Nov 25, 6:01PM CST
Image: HP. The stock market is often relatively quiet right before a holiday, and Wednesday's closing numbers bore that out. Yet even though the Dow and S&P 500 were narrowly mixed in today's trading session, several stocks posted dramatic...
PBR: 7.47 (+0.35), ABGB: 1.02 (-0.36), HPQ: 13.08 (+0.23)


New plant tests US appetite for seawater desalination
By ELLIOT SPAGAT - AP - Sun Nov 01, 11:00AM CST
CARLSBAD, Calif. (AP) — There's far more riding on the Americas' largest seawater desalination plant than the 50 million gallons of drinking water it will produce for the San Diego area each day.
ABGB: 1.02 (-0.36)

TRADING ALERT: Rosen Law Firm Reminds Abengoa, S.A. Investors of Important October 9, 2015 Deadline and Expanded Class Period in Class Action- ABGB
BusinessWire - Thu Oct 08, 10:25AM CDT
Rosen Law Firm, a global investor rights firm, reminds purchasers of Abengoa, S.A. (NASDAQ:ABGB) American Depository Shares from October 13, 2013 through August 2, 2015, inclusive (the "Class Period" of the important October 9, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover investors' losses under the federal securities laws.
ABGB: 1.02 (-0.36)

GPM Announces the Filing of a Securities Class Action on Behalf of Abengoa, S.A. Investors
BusinessWire - Wed Oct 07, 7:58PM CDT
Glancy Prongay & Murray LLP ("GPM" announces the filing of a class action lawsuit on behalf of investors of Abengoa, S.A. ("Abengoa" or the "Company" (NASDAQ:ABGB) securities between October 17, 2013 and August 2, 2015, both dates inclusive (the "Class Period".
ABGB: 1.02 (-0.36)

UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Abengoa, S.A. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit - ABGB
GlobeNewswire - Sat Oct 03, 6:00AM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Abengoa, S.A. ("Abengoa" or the "Company" (Nasdaq:ABGB) American Depositary Shares (ADSs) during the period between November 12, 2014 and August 2, 2015, inclusive (the "Class Period". Investors who wish to become proactively involved in the litigation have until October 9, 2015 to seek appointment as lead plaintiff.
ABGB: 1.02 (-0.36)

Block & Leviton Reminds Investors of Upcoming Deadline In Shareholder Litigation Against Abengoa SA. and Certain of Its Officers and Directors
PR Newswire - Thu Oct 01, 9:25AM CDT
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the upcoming deadline in the pending securities litigation against Abengoa SA ("Abengoa" or the "Company" (NASDAQ: ABGB) and three of its current or former officers, one of whom is also a member of its board of directors. Shareholders have until Friday, October 9, 2015, to seek appointment as lead plaintiff in this action. If you are interested in the lawsuit or in becoming a lead plaintiff, please contact attorney Steven P. Harte, at (617) 398-5600 or email him at Steven@blockesq.com.
ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Abengoa, S.A. of Pendency of Class Action Lawsuit and Expanded Class Period -- ABGB
GlobeNewswire - Wed Sep 30, 10:29AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ABGB: 1.02 (-0.36)

ALERT: Rosen Law Firm Reminds Abengoa, S.A. Investors of Important October 9, 2015 Deadline in Class Action- ABGB
GlobeNewswire - Tue Sep 29, 3:26PM CDT
Rosen Law Firm, a global investor rights firm, reminds purchasers of Abengoa, S.A. (NASDAQ:ABGB) American Depository Shares from November 12, 2014 through August 2, 2015, inclusive (the "Class Period" of the important October 9, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover investors' losses under the federal securities laws.
ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Abengoa, S.A. of Class Action Lawsuit and Upcoming Deadline - ABGB
GlobeNewswire - Fri Sep 25, 4:16PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Abengoa, S.A. ("Abengoa" or the "Company" (NASDAQ:ABGB) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 15-cv-06971, is on behalf of a class consisting of all persons or entities who purchased Abengoa American Depositary Shares ("ADSs" securities between October 17, 2013 and August 2, 2015 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
ABGB: 1.02 (-0.36)

New Strong Sell Stocks for September 24th
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Thursday
BPY: 23.50 (+0.40), FSAM: 4.04 (+0.11), AXTA: 27.17 (+0.49), ENB: 41.32 (-0.07), ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abengoa, S.A. of Pendency of Class Action Lawsuit and Expanded Class Period
BusinessWire - Mon Sep 21, 5:02PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ABGB: 1.02 (-0.36)

INVESTOR ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Abengoa, S.A. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Thu Sep 17, 4:46PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Abengoa, S.A. ("Abengoa" or the "Company" (Nasdaq: ABGB) American Depositary Shares (ADSs) during the period between November 12, 2014 and August 2, 2015, inclusive (the "Class Period". Investors who wish to become proactively involved in the litigation have until October 9, 2015 to seek appointment as lead plaintiff.
ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving Abengoa, S.A. and a Lead Plaintiff Deadline of October 9, 2015 - ABGB
GlobeNewswire - Wed Sep 16, 4:22PM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Abengoa, S.A. (NASDAQ:ABGB) securities between October 13, 2013 and August 2, 2015.
ABGB: 1.02 (-0.36)

Abengoa wins a new engineering and construction project in Denmark
GlobeNewswire - Thu Sep 10, 1:56AM CDT
-- Nyt Herlev Hospital has selected Abengoa to carry out the electromechanical installations of the new hospital complex located in the town of Herlev, Denmark.
ABGB: 1.02 (-0.36)

The Law Offices of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Abengoa, S.A. Investors
BusinessWire - Wed Sep 09, 8:30AM CDT
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Abengoa, S.A. ("Abengoa" or the "Company" (NASDAQ:ABGB) securities between October 17, 2013 and August 2, 2015, both dates inclusive (the "Class Period". Investors who suffered losses on their investment in Abengoa securities are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights.
ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Abengoa, S.A. and Certain Officers - ABGB
GlobeNewswire - Tue Sep 08, 3:56PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Abengoa, S.A. ("Abengoa" or the "Company" (NASDAQ:ABGB) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 15-cv-06971, is on behalf of a class consisting of all persons or entities who purchased Abengoa American Depositary Shares ("ADSs" securities between October 17, 2013 and August 2, 2015 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
ABGB: 1.02 (-0.36)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Abengoa, S.A. of Pendency of Class Action Lawsuit and Expanded Class Period - ABGB
PR Newswire - Tue Sep 08, 11:41AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
ABGB: 1.02 (-0.36)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVid Debuts AI to Mimic Physician Decision-Making

Updated Category News Views 47

Revolutionizing Understanding: BioVid Mimetics™ Now here's something that's shaking the research tree: BioVid's launching Mimetics™, and it's a big deal. They've come up with AI that can mirror how physicians think and decide. This ain't your run-of-the-mill tech stuff—it's groundbreaking in understanding physician decision-making. The Core: How Do Doctors Really...

Continue Reading
Acqualina Resort's Sustainable Commitment Earns Praise

Updated Category News Views 52

Sustainability at the Heart of Luxury Spotlight's on Acqualina Resort again. The folks there have snagged the 2026 VERIFIED™ Responsible Hospitality badge from Forbes Travel Guide for the third straight year. Means they’re more than just a pretty face down in Miami. This accolade puts them slap bang among the best in sustainable luxury. Forbes doesn’t just hand...

Continue Reading
Divorce Expertise: Obenhaus Adds CDFA Credential

Updated Category News Views 84

Divorce isn't just a legal tangled mess; it's a financial minefield as well. Lindsey Obenhaus from Goranson Bain Ausley has beefed up her credentials with a Certified Divorce Financial Analyst® (CDFA®) designation, lending a sharper edge to her approach in divorce financials. When relationships turn sour, so do wallets, and Obenhaus aims to soften that blow for her...

Continue Reading
Howard Hughes Joins S&P SmallCap 600, Arcosa Out

Updated Category News Views 45

Shakeup in the S&P SmallCap 600 It’s one of those days where something shifts in the market landscape—Howard Hughes Holdings Inc. (NYSE: HHH) is swaggering into the S&P SmallCap 600. Kicking off on October 28, it's got quite the entrance lined up. On the other end, Arcosa Inc. (NYSE: ACA) is making a hasty exit after getting scooped up by CRH plc (NYSE: CRH). For...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 15

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Amy Johnson Steps Up as GDIT President Amid Shifts

Updated Category News Views 68

A New Chapter for GDIT with a Veteran Leader Big shoes to fill? Nah, more like Amy Johnson was made for these shoes. Stepping up as president of General Dynamics Information Technology (GDIT) on November 3, she’s got 27 years of experience under her belt, all from General Dynamics' own backyard. This ain't her first rodeo. From tightrope-walking the perils of defense...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 40

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 64

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
University of Phoenix Unveils Credit for Prior Learning Advantages

Updated Category News Views 27

Navigating College Credits with Life Experience If you think school is the only place to pick up education that counts, think again. University of Phoenix is challenging this by recognizing the value of the hustle and grind working adults go through. During the recently wrapped-up National Transfer Student Week, Devin Andrews, their VP of Admissions and Evaluation, shed...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 142

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading

Top 5 Most Recently Viewed Articles

VERSES AI Secures Major Contract with Global Investment Firm

Updated Category News Views 183

Strategic Move by VERSES AI VERSES AI Inc. has made an impressive leap in the cognitive computing sector by securing a contract with a leading global investment firm. This partnership is rooted in the recent success of the company's Genius beta program, where initial evaluations highlighted the platform's remarkable capabilities. Enterprise Agreement Details As part of...

Continue Reading
Expected Growth of Agricultural Adjuvants Market to USD 6.2B

Updated Category News Views 143

The Agricultural Adjuvants Market: An Overview The Agricultural Adjuvants Market is witnessing remarkable growth as demand for crop protection products increases. Recent studies estimate that the market, valued at around USD 3.9 billion, is projected to reach approximately USD 6.2 billion by 2034. This translates to a compound annual growth rate (CAGR) of about 4.78% from...

Continue Reading
Understanding CVS Health Inc.'s P/E Ratio in Depth

Updated Category News Views 428

Analyzing the Price-to-Earnings Ratio of CVS Health Inc. In the current trading session, CVS Health Inc. (NYSE: CVS) is trading at a price of $79.86, experiencing a slight decrease of 0.01%. Over the past month, the stock has shown a decline of about 0.99%. However, looking back over the last year, the company's stock has seen a remarkable increase of 44.98%. This...

Continue Reading
Lead the Charge: Edwards Lifesciences Shareholders Unite

Updated Category News Views 138

Understanding the Class Action for Edwards Lifesciences Investors If you are an investor in Edwards Lifesciences Corporation (NYSE: EW), it is crucial to be aware of your rights and options, especially in the wake of substantial losses. Recent developments have opened the door for investors to come together and pursue a collective legal approach toward holding the company...

Continue Reading
Johnson Fistel Investigates Centuri's Stock Price Decline

Updated Category News Views 46

Investigating Centuri Holdings, Inc. Johnson Fistel, LLP, a well-regarded shareholder rights law firm, has initiated an investigation into Centuri Holdings, Inc. (NYSE: CTRI) following a noteworthy decline in the company’s stock price. The firm is examining whether there were any violations of securities laws by the company's executives who may have misrepresented or...

Continue Reading